BioCurex, Inc.(fka BOCX)

[Gold Seeker]

Tommyb, I posted the information on Constab last year and also communicated with the CEO, Stephane Gagne. They were looking for financing and very willing to communicate. They are indeed using AFP receptors to deliver drugs to cancer cells. Notice that they state RECAF is not present or only present to a small extent on normal cells. I don't know if that is correct but it is different than the exclusive statement by Biocurex that it is not present on normal cells.

Their research is one of the reasons Dr. Moro elected to do large financing. As I also have pointed out, their appear to be at least four different groups that are using RECAF to deliver drugs beside BioCurex. Dr. Moro was getting left at the gate in therapeutics for lack of funding. To dilute extensively at this level hurts but it is obvious that Dr. Moro places success in treating cancer substantially higher that the desires of share holders.